Jarry et al., 2011 - Google Patents
Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathwaysJarry et al., 2011
View HTML- Document ID
- 15358210926781210073
- Author
- Jarry A
- Bossard C
- Sarrabayrouse G
- Mosnier J
- Laboisse C
- Publication year
- Publication venue
- Gastroenterology
External Links
Snippet
BACKGROUND & AIMS: Signaling via interleukin (IL)-10 or transforming growth factor (TGF)- β is disrupted in subpopulations of patients with inflammatory bowel disease, but it is not clear how a T-helper (Th) 1 cell response is induced. We studied conversion of human …
- 102000004887 Transforming Growth Factor beta 0 title abstract description 79
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bamias et al. | Proinflammatory effects of TH2 cytokines in a murine model of chronic small intestinal inflammation | |
| Jarry et al. | Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathways | |
| JP6416855B2 (en) | Use of low dose IL-2 for the treatment of autoimmune related disorders or inflammatory disorders | |
| Sun et al. | Novel immunoregulatory properties of EGCG on reducing inflammation in EAE | |
| Polanczyk et al. | Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice | |
| Park et al. | Adipose-derived stem cells ameliorate colitis by suppression of inflammasome formation and regulation of M1-macrophage population through prostaglandin E2 | |
| JP6054889B2 (en) | Use of low dose IL-2 for the treatment of autoimmune related disorders or inflammatory disorders | |
| Zang et al. | Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-κB | |
| KR100913405B1 (en) | Ｔｈ２－composition for the prevention or treatment of mediated immune diseases | |
| Boirivant et al. | A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis | |
| Ahmadi et al. | Sirolimus as a new drug to treat RIF patients with elevated Th17/Treg ratio: A double-blind, phase II randomized clinical trial | |
| US10953071B2 (en) | Compositions and methods for treatment of intracellular damage and bacterial infection | |
| Wang et al. | Nr4a1 plays a crucial modulatory role in Th1/Th17 cell responses and CNS autoimmunity | |
| Li et al. | Recombinant adiponectin alleviates abortion in mice by regulating Th17/Treg imbalance via p38MAPK-STAT5 pathway | |
| Jiang et al. | Inhibition effect of blunting Notch signaling on food allergy through improving TH1/TH2 balance in mice | |
| US20160038447A1 (en) | Modulation of regulatory t cells via g-coupled protein receptor 43 | |
| Cai et al. | Interleukin 23 regulates the functions of human decidual immune cells during early pregnancy | |
| Lunin et al. | Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis | |
| Wang et al. | Changes among TGF-β1+ Breg cells and helper T cell subsets in a murine model of allergic rhinitis with prolonged OVA challenge | |
| Bauer et al. | Evaluation of immune parameters in depressed patients | |
| KR20160101944A (en) | Bacterial influence on regulation of appetite via clpb protein mimicry of alpha-msh | |
| Xie et al. | Luteolin alleviates ulcerative colitis by restoring the balance of NCR-ILC3/NCR+ ILC3 to repairing impaired intestinal barrier | |
| Aslanian-Kalkhoran et al. | The effect of lymphocyte immunotherapy (LIT) in modulating immune responses in patients with recurrent pregnancy loss (RPL) | |
| Chen et al. | Effects of 1, 25-dihydroxyvitamin D3 in an ovalbumin-induced allergic rhinitis model | |
| Arnaboldi et al. | Suppression of Th1 and Th17, but not Th2, responses in a CD8+ T cell-mediated model of oral tolerance |